Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

67.22 -1.72 (-2.49%)
Official Closing Price Updated: 4:00 PM EDT, Jul 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,224,897
Open 69.49
Bid (Size) 67.03 (1)
Ask (Size) 67.76 (13)
Prev. Close 68.94
Today's Range 66.71 - 69.49
52wk Range 57.00 - 143.49
Shares Outstanding N/A
Dividend Yield 3.27%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Absurdly Cheap Growth Stocks to Load Up On Right Now
Via The Motley Fool
Topics World Trade

Performance

YTD
-23.2%
-23.2%
1 Month
-12.7%
-12.7%
3 Month
+1.8%
+1.8%
6 Month
-20.6%
-20.6%
1 Year
-52.5%
-52.5%

More News

Read More
How To Trade This 150% Gainer Chasing A Cure For Type 1 Diabetes
Via Benzinga
3 Dividend Growth Stocks to Buy and Hold
Via The Motley Fool
Topics Intellectual Property
Magnificent 7 Crush EU Giants—Jamie Dimon Tells Europe: 'You're Losing'
Via Benzinga
3 Reasons I Bought Novo Nordisk Stock Instead of Eli Lilly
Via The Motley Fool
Zepbound Powers Eli Lilly's Upbeat Q2 Outlook
Via Benzinga
Dow Futures Edge Up As Trump Prepares More Tariff Letters: Freeport, UnitedHealth, Meta, Novo Nordisk, AstraZeneca Among Stocks In Focus
Via Stocktwits
Topics ETFs Government Stocks
Novo Nordisk Seeks Approval For Higher Wegovy Dose In Europe
Via Stocktwits
Does Higher Dose Of Wegovy Result In More Weight Loss? Novo Nordisk Seeks European Approval
Via Benzinga
WeightWatchers Sheds $1.15 Billion In Debt To Fuel Transformation
Via Benzinga
2 S&P 500 Dividend Stocks That Could Climb 17% or More, According to Wall Street
Via The Motley Fool
Topics Stocks
Options Corner: Bullish Traders Eye Eli Lilly As Market Signals Hint At A Turnaround
Via Benzinga
Hims & Hers Navigates Novo Nordisk Breakup And Compounding Lawsuits
Via Benzinga
Wegovy, Zepbound Prices Drop, But Most Patients Still Can't Afford Long-Term Use: 'Coverage Is Not The Same As Access,' Says Expert
Via Benzinga
Better Growth Buy: Eli Lilly vs. Viking Therapeutics
Via The Motley Fool
2 Stocks to Buy on the Dip and Hold for 10 Years
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Is Hims & Hers Stock in Trouble?
Via The Motley Fool
Topics Supply Chain
Novo Nordisk Ignored Internal Warnings On Wegovy Launch Preparedness: Report
Via Benzinga
Amazon Wants More Power
Via The Motley Fool
Topics Artificial Intelligence
Got $200? 2 Biotech Stocks to Buy and Hold Forever
Via The Motley Fool
Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?
Via Investor's Business Daily
Circle Internet, Hims & Hers Health And CoreWeave Are Among Top 10 Large Cap Losers Last Week (June 23-27): Are The Others In Your Portfolio?
Via Benzinga
3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking
Via MarketBeat
Topics Artificial Intelligence Economy

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 67.22
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 07/15/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.